Literature DB >> 2251034

Response to diet and cholestyramine in a patient with sitosterolemia.

P F Belamarich1, R J Deckelbaum, T J Starc, B E Dobrin, G S Tint, G Salen.   

Abstract

In this report, an 11-year-old boy with diffuse tendinous and tuberous xanthomatosis and a plasma sterol concentration of 555 mg/dL, consisting primarily of cholesterol, is described. Three months after changing from an unrestricted diet to a cholesterol-lowering diet, his plasma sterol concentration decreased to 221 mg/dL. Because of the degree and rapidity of his response to diet, sitosterolemia was suspected. According to results of capillary gas-liquid chromatography of his plasma sterols, there was a sitosterol concentration of 31.3 mg/dL (normal less than 1.0 mg/dL), establishing the diagnosis of sitosterolemia. Addition of cholestyramine therapy (8 g/d) to a low sterol diet further lowered his plasma sterol concentration to 173 mg/dL and led to complete regression of all tuberous xanthomata. Tendinous xanthomata regressed at a slower rate. These findings show that the diagnosis of sitosterolemia should be suspected in severely hypercholesterolemic children (total cholesterol greater than 400 mg/dL) whose plasma cholesterol level is highly responsive to dietary manipulation. The rapid and sustained lowering of plasma cholesterol and regression of xanthomata after treatment with diet and cholestyramine suggest that sitosterolemia is a treatable cause of premature atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2251034

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  Clinical observations, molecular genetic analysis, and treatment of sitosterolemia in infants and children.

Authors:  Dau-Ming Niu; Kah-Wai Chong; Ju-Hui Hsu; Tina Jui-Ting Wu; Hsiao-Chi Yu; Cheng-Hung Huang; Ming-Yu Lo; Ching Fai Kwok; Lisa E Kratz; Low-Tone Ho
Journal:  J Inherit Metab Dis       Date:  2010-06-03       Impact factor: 4.982

2.  Sitosterolaemia in Switzerland: molecular genetics links the US Amish-Mennonites to their European roots.

Authors:  C Solcà; Z Stanga; B Pandit; P Diem; J Greeve; S B Patel
Journal:  Clin Genet       Date:  2005-08       Impact factor: 4.438

Review 3.  Plant Sterols, Stanols, and Sitosterolemia.

Authors:  Bridget O Ajagbe; Rgia A Othman; Semone B Myrie
Journal:  J AOAC Int       Date:  2015-05-04       Impact factor: 1.913

Review 4.  Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.

Authors:  Helen H Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Sitosterolemia Presenting as Pseudohomozygous Familial Hypercholesterolemia.

Authors:  Christian Renner; William E Connor; Robert D Steiner
Journal:  Clin Med Res       Date:  2016-05-26

Review 6.  ABC transporters, atherosclerosis and inflammation.

Authors:  Michael L Fitzgerald; Zahedi Mujawar; Norimasa Tamehiro
Journal:  Atherosclerosis       Date:  2010-01-21       Impact factor: 5.162

7.  Phytosterol feeding causes toxicity in ABCG5/G8 knockout mice.

Authors:  Allison L McDaniel; Heather M Alger; Janet K Sawyer; Kathryn L Kelley; Nancy D Kock; J Mark Brown; Ryan E Temel; Lawrence L Rudel
Journal:  Am J Pathol       Date:  2013-02-01       Impact factor: 4.307

8.  Phytosterolaemia in three unrelated South African families.

Authors:  G M Berger; W M Deppe; A D Marais; M Biggs
Journal:  Postgrad Med J       Date:  1994-09       Impact factor: 2.401

9.  Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion.

Authors:  Liqing Yu; Robert E Hammer; Jia Li-Hawkins; Klaus Von Bergmann; Dieter Lutjohann; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

10.  Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia.

Authors:  G Salen; K von Bergmann; D Lütjohann; P Kwiterovich; J Kane; S B Patel; T Musliner; P Stein; B Musser
Journal:  Circulation       Date:  2004-02-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.